Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation. [electronic resource]
- Scientific reports 01 2020
- 663 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-019-57153-9 doi
Antibodies Antibodies, Monoclonal--pharmacology Antineoplastic Agents Cell Membrane--metabolism Cells, Cultured DNA-Binding Proteins Endocytosis--drug effects Endosomal Sorting Complexes Required for Transport Endosomes--metabolism ErbB Receptors--metabolism Head and Neck Neoplasms--drug therapy Humans Lysosomes--metabolism Phosphoproteins Protein Transport Receptors, Cell Surface Transcription Factors